Skip to content

The effect and mechanism of glycopyrronium bromide on the cognitive function after hip arthroplasty in the elderly and its mechanism

The effect of glycopyrronium bromide on the cognitive function after hip arthroplasty in the elderly and its mechanism

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078825
Enrollment
Unknown
Registered
2023-12-19
Start date
2023-12-20
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group G:Glycopyrronium 4ug/kg was administered intravenouslyup G
Group W:Penehyclidine hydrochloride 10ug/kg was administered intravenously

Sponsors

The Second Affiliated Hospital of Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: The age ranged from 65 to 85 years. b. Undergoing total hip replacement within 3 hours; C. Asa grade I-III; d. Patients volunteered to take the test and signed the informed consent; e. No use of free depressant drugs before surgery; f. No obvious abnormality of liver and kidney function; g. no myocardial infarction in the last 3 months; h. no endocrine system disease; j. Body-mass index (BMI) of 18-25.

Exclusion criteria

Exclusion criteria: a. Diseases that may affect postoperative cognitive function; b. excessive obesity; c. Allergy to anticholinergic drugs; d. severe visual or hearing impairment; Inability to communicate effectively with a psychologist; Or unable to complete the neuropsychological test due to educational background; e. poor preoperative pulmonary oxygenation; Patients with pulse oxygen < 90% and inhaled pure oxygen < 95%; f The total score of preoperative mini-mental state Examination was less than 24; g. Patients diagnosed with sleep quality disorders before surgery;

Design outcomes

Primary

MeasureTime frame
Measures OF COGNITIVE FUNCTION;Measurement of S100A12, IL-6, and TNF-a;Sleep QUALITY MONITORING;Duration of stay in the resuscitation room;

Secondary

MeasureTime frame
Vital signs ;time of operation;Duration of anesthesia;Recovery time of spontaneous breathing;Time of tracheal tube removal;

Countries

China

Contacts

Public ContactShi Wenyan

The Second Affiliated Hospital of Zunyi Medical University

286423028@qq.com+86 133 6852 7097

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026